KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $429.9 million.

  • Novavax's Total Current Liabilities fell 63.60% to $429.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.9 million, marking a year-over-year decrease of 63.60%. This contributed to the annual value of $1.2 billion for FY2024, which is 29.40% down from last year.
  • Per Novavax's latest filing, its Total Current Liabilities stood at $429.9 million for Q3 2025, which was up 10.47% from $389.1 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Total Current Liabilities peaked at $2.5 billion during Q4 2022, and registered a low of $389.1 million during Q2 2025.
  • For the 3-year period, Novavax's Total Current Liabilities averaged around $1.1 billion, with its median value being $1.2 billion (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 6,266.85% in 2021, then crashed by 66.39% in 2025.
  • Novavax's Total Current Liabilities (Quarterly) stood at $2.4 billion in 2021, then increased by 2.91% to $2.5 billion in 2022, then slumped by 33.53% to $1.6 billion in 2023, then decreased by 29.40% to $1.2 billion in 2024, then crashed by 63.60% to $429.9 million in 2025.
  • Its Total Current Liabilities was $429.9 million in Q3 2025, compared to $389.1 million in Q2 2025 and $422.2 million in Q1 2025.